- Home
- WRAP vs EYEN Comparison
WRAP vs EYEN Comparison
Compare WRAP & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- EYEN
- Stock Information
- Founded
- WRAP 2016
- EYEN 2014
- Country
- WRAP United States
- EYEN United States
- Employees
- WRAP N/A
- EYEN N/A
- Industry
- WRAP Ordnance And Accessories
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- WRAP Industrials
- EYEN Health Care
- Exchange
- WRAP Nasdaq
- EYEN Nasdaq
- Market Cap
- WRAP 68.8M
- EYEN 38.2M
- IPO Year
- WRAP N/A
- EYEN 2018
- Fundamental
- Price
- WRAP $1.70
- EYEN $0.55
- Analyst Decision
- WRAP
- EYEN Strong Buy
- Analyst Count
- WRAP 0
- EYEN 2
- Target Price
- WRAP N/A
- EYEN $12.00
- AVG Volume (30 Days)
- WRAP 191.1K
- EYEN 879.0K
- Earning Date
- WRAP 10-15-2024
- EYEN 11-11-2024
- Dividend Yield
- WRAP N/A
- EYEN N/A
- EPS Growth
- WRAP N/A
- EYEN N/A
- EPS
- WRAP N/A
- EYEN N/A
- Revenue
- WRAP $7,269,000.00
- EYEN $31,405.00
- Revenue This Year
- WRAP N/A
- EYEN $50,309.30
- Revenue Next Year
- WRAP N/A
- EYEN $421.63
- P/E Ratio
- WRAP N/A
- EYEN N/A
- Revenue Growth
- WRAP 0.99
- EYEN N/A
- 52 Week Low
- WRAP $1.21
- EYEN $0.37
- 52 Week High
- WRAP $7.01
- EYEN $2.57
- Technical
- Relative Strength Index (RSI)
- WRAP 56.79
- EYEN 52.60
- Support Level
- WRAP $1.71
- EYEN $0.52
- Resistance Level
- WRAP $1.93
- EYEN $0.59
- Average True Range (ATR)
- WRAP 0.16
- EYEN 0.05
- MACD
- WRAP 0.01
- EYEN 0.01
- Stochastic Oscillator
- WRAP 61.70
- EYEN 66.45
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.